Valuation Lexicon Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-02 EDT			5-day change	1st Jan Change
1.820 ^USD	0.00%		+1.39%	+58.26%

09-09	Lexicon Pharmaceuticals, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 11:20 AM
08-31	Lexicon Pharmaceuticals Announces Results from Post Hoc Soloist-Whf Analysis Demonstrating Consistent Sotagliflozin Results Across Baseline Blood Pressure Levels in Patients with Recent Worsening Heart Failure	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	586.6	360.5	373.4	267	417.9	809.8	-	-
Change	-	-38.56%	3.58%	-28.5%	56.54%	93.78%	-	-
Enterprise Value (EV)	499.9	360.5	373.4	267	417.9	809.8	809.8	809.8
Change	-	-27.89%	3.58%	-28.5%	56.54%	93.78%	0%	0%
P/E	-6.57x	-3.08x	-1.94x	-1.17x	-8.21x	-10.7x	-9.1x	-14.9x
PBR	5.17x	-	-	-	-	-	-	-
PEG	-	-0.92x	-0.1x	0.1x	0.1x	-0.5x	-0.5x	0.4x
Capitalization / Revenue	1,969x	2,593x	310x	8.59x	8.39x	21.8x	47.8x	11.4x
EV / Revenue	0x	0x	0x	0x	0x	21.8x	47.8x	11.4x
EV / EBITDA	-0x	-0x	-0x	-0x	-0x	-12.1x	-7.99x	-15x
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-11.3x	-7.31x	-10.3x
EV / FCF	-	-	-	-	-	-	-7,603,942x	-8,879,603x
FCF Yield	-	-	-	-	-	-	-0%	-0%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.6	-0.62	-0.79	-0.63	-0.14	-0.17	-0.2	-0.122
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	0.298	0.139	1.204	31.08	49.8	37.17	16.93	71.2
EBITDA ¹	-86.8	-100.3	-171.2	-196.6	-48.29	-66.71	-101.4	-53.92
EBIT ¹	-87.09	-100.8	-171.8	-197.1	-48.91	-71.52	-110.8	-78.85
Net income ¹	-87.76	-101.9	-175.6	-200.4	-50.34	-73.77	-97.05	-68.54
Net Debt	-86.74	-	-	-	-	-	-	-
Reference price ²	3.940	1.910	1.530	0.738	1.150	1.820	1.820	1.820
Nbr of stocks (in thousands)	148,896	188,726	244,025	361,492	363,399	444,956	-	-
Announcement Date	2/28/22	3/2/23	3/11/24	3/6/25	3/5/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LEXICON PHARMACEUTICALS, INC.	-10.71x	-	-	-.--%	810M
WUXI APPTEC CO., LTD.	21.73x	7.71x	15.48x	1.37%	74.16B
ARGENX SE	29.82x	8.57x	26.7x	0.04%	57.39B
LONZA GROUP AG	32.98x	5.93x	17.77x	0.98%	47.64B
REVOLUTION MEDICINES, INC.	-21.31x	230.81x	-22.97x	-.--%	44.29B
IQVIA HOLDINGS INC.	33.26x	3.23x	13.97x	-.--%	42.5B
BEONE MEDICINES AG	46.77x	5.41x	29.66x	-.--%	40.71B
CELLTRION, INC.	27.63x	7.93x	20.48x	0.41%	30.97B
WUXI BIOLOGICS (CAYMAN) INC.	32.99x	7.05x	18.3x	-.--%	28.53B
BIONTECH SE	-15.1x	5.68x	-7.14x	-.--%	24.34B
Average	17.81x	31.37x	12.47x	0.28%	39.13B
Weighted average by Cap.	22.20x	32.04x	13.55x	0.42%